Efficacy and safety evaluation of plasma-derived human coagulation factor Ⅷ in patients with hemophilia A

Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 9

Abstract

Objective To evaluate the efficacy and safety of plasma-derived human coagulation factor Ⅷ (FⅧ) in the treatment of patients with hemophilia A. Methods A multi-center and open, SAT(single-arm trials) clinical study was conducted. A total of 54 subjects with hemophilia A were enrolled in 5 research centers. FⅧ was injected according to the subjects' weight, severity of disease and other factors, and the transfusion efficiency of FⅧ activity at 10 min after the first infusion of the first bleeding event was taken as the main efficacy indexes. The improvement scores of bleeding symptoms and signs within 24 h after the first infusion of the first bleeding event were the secondary efficacy indexes. The pathogenic microbial indexes and FⅧ inhibitors were detected on 90(th) and 180(th) day after treatment. Results The transfusion efficiency of FⅧ activity of 54 subjects at 10 min after the first infusion was 171.9% on average, with median of 169.5%, both higher than the target value of 100%. Within 24 h after the first infusion, the improvement of bleeding symptoms and signs of the subjects were scored, among which 19 cases (35.2%) were "obvious", 35 cases (64.8%) were "good", and the total clinical effective rate reached 100%. Five subjects (9.3%) had six drug-related adverse events. On 90(th) and 180(th) day after treatment, hepatitis B surface antigen, hepatitis C antibody, HIV antibody, treponema pallidum antibody and FⅧ inhibitors were detected, and no negative to positive cases were found. Conclusion After infusion, the FⅧ preparation can significantly improve the FⅧ activity level in hemophilia A patients in a short period of time, which has high infusion efficiency and can achieve better treatment efficacy, and can also effectively control and relieve bleeding symptoms and signs, with good overall safety.

Authors and Affiliations

Shumin LIANG, Wei ZHANG, Guixiang JIANG, Zhongliang SUN, Yan ZHENG, Chen YAN

Keywords

Related Articles

Skin injury around enterostomy cured by allogeneic platelet-rich plasma: a report of two cases

Objective To investigate the feasibility of allogeneic platelet-rich plasma (PRP) for the treatment of skin injury around enterostomy. Methods The treatment process by PRP of 2 patients with skin injury around enterostom...

Viral selection pressure and CD4+T cell epitope in HLA-DRB1 * 11:01 of HCV infected patients

Objective HLA-DRB1 * 11:01, as a class HLA-Ⅱ gene, was reported to be associated with spontaneous clearance of HCV in Han and Li population. Our study was to investigate the effects of viral selection pressure and CD4+T...

Correlation analysis between free blood use of donors and repeated blood donation intention in Changsha

Objective To understand the situation of free blood use of blood donors in Changsha to explore the correlation between free blood use of donors and repeated blood donation behaviors, so as to provide a theoretical basis...

Preparation quality control and clinical application observation of pooled platelets with leukocytes reduced

Objective To investigate the preparation quality and clinical application effect of pooled platelets with leukocytes reduced. Methods The quality and clinical effect of the buffy-coated method prepared pooled platelets l...

Application of inspection sheet in apheresis platelet collection

Objective To explore the effect of inspection sheet on improving the quality of apheresis platelet, the satisfaction of blood donors and the cooperation ability of phlebotomists in the process of apheresis platelet colle...

Download PDF file
  • EP ID EP738634
  • DOI 10.13303/j.cjbt.issn.1004-549x.2023.09.007
  • Views 4
  • Downloads 0

How To Cite

Shumin LIANG, Wei ZHANG, Guixiang JIANG, Zhongliang SUN, Yan ZHENG, Chen YAN (2023). Efficacy and safety evaluation of plasma-derived human coagulation factor Ⅷ in patients with hemophilia A. Chinese Journal of Blood Transfusion, 36(9), -. https://europub.co.uk/articles/-A-738634